Instrument Inactif

Autres langues Yew Bio-Pharm Group, Inc. Other OTC

Actions

YEWB

US98584C1018

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

YEW BIO-PHARM GROUP, INC. : Change in Directors or Principal Officers (form 8-K)	29/03/22
Yew Bio-Pharm Group, Inc. Announces Yongchun Shi and Mr. Xiefeng Liu Resigned as the Independent Director	29/03/22
YEW BIO-PHARM GROUP, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	15/11/21
Yew Bio-Pharm Group, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	15/11/21
YEW BIO PHARM : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	16/08/21
Yew Bio-Pharm Group, Inc. Announces Earnings Results for the Second Quarter Ended June 30, 2021	16/08/21
YEW BIO-PHARM GROUP, INC. : Change in Directors or Principal Officers (form 8-K)	27/07/21
Yew Bio-Pharm Group, Inc. Announces Executive Changes	27/07/21
Yew Bio-Pharm Group, Inc. Announces Executive Changes	27/07/21
Yew Bio-Pharm Group, Inc. Announces Executive Changes	27/07/21
YEW BIO PHARM : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	17/05/21
Yew Bio-Pharm Group, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	17/05/21
YEW BIO P : PHARM GROUP, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	30/03/21
Yew Bio-Pharm Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	30/03/21
Yew Bio Pharm : Announces New Cosmetic Subsidiary	09/03/21
Yew Bio-Pharm Group, Inc. Announces New Cosmetic Subsidiary	09/03/21
YEW BIO-PHARM GROUP, INC. : Change in Directors or Principal Officers (form 8-K)	05/01/21
Yew Bio-Pharm Group, Inc. Announces Resignation of Guoshuang Tian as Director	05/01/21
Yew Bio-Pharm Group, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	13/11/20
YEW BIO PHARM : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	13/11/20

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Yew Bio-Pharm Group, Inc. Other OTC

Actions

YEWB

US98584C1018

Autres langues

Filtres